Cargando…
Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645467/ http://dx.doi.org/10.1186/2051-1426-3-S2-O11 |
| _version_ | 1782400819107201024 |
|---|---|
| author | Ahmed, Nabil Brawley, Vita Hegde, Meenakshi Bielamowicz, Kevin Wakefield, Amanda Ghazi, Alexia Ashoori, Aidin Diouf, Oumar Gerken, Claudia Landi, Daniel Kalra, Mamta Yi, Zhongzhen Rooney, Cliona Dotti, Gianpietro Gee, Adrian Heslop, Helen Gottschalk, Stephen Powell, Suzanne Grossman, Robert Wels, Winfried Kew, Yzonne Baskin, David Zhang, Jonathan New, Pamela Hicks, John |
| author_facet | Ahmed, Nabil Brawley, Vita Hegde, Meenakshi Bielamowicz, Kevin Wakefield, Amanda Ghazi, Alexia Ashoori, Aidin Diouf, Oumar Gerken, Claudia Landi, Daniel Kalra, Mamta Yi, Zhongzhen Rooney, Cliona Dotti, Gianpietro Gee, Adrian Heslop, Helen Gottschalk, Stephen Powell, Suzanne Grossman, Robert Wels, Winfried Kew, Yzonne Baskin, David Zhang, Jonathan New, Pamela Hicks, John |
| author_sort | Ahmed, Nabil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645467 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46454672015-11-20 Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. Ahmed, Nabil Brawley, Vita Hegde, Meenakshi Bielamowicz, Kevin Wakefield, Amanda Ghazi, Alexia Ashoori, Aidin Diouf, Oumar Gerken, Claudia Landi, Daniel Kalra, Mamta Yi, Zhongzhen Rooney, Cliona Dotti, Gianpietro Gee, Adrian Heslop, Helen Gottschalk, Stephen Powell, Suzanne Grossman, Robert Wels, Winfried Kew, Yzonne Baskin, David Zhang, Jonathan New, Pamela Hicks, John J Immunother Cancer Oral Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645467/ http://dx.doi.org/10.1186/2051-1426-3-S2-O11 Text en Copyright © 2015 Ahmed et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Ahmed, Nabil Brawley, Vita Hegde, Meenakshi Bielamowicz, Kevin Wakefield, Amanda Ghazi, Alexia Ashoori, Aidin Diouf, Oumar Gerken, Claudia Landi, Daniel Kalra, Mamta Yi, Zhongzhen Rooney, Cliona Dotti, Gianpietro Gee, Adrian Heslop, Helen Gottschalk, Stephen Powell, Suzanne Grossman, Robert Wels, Winfried Kew, Yzonne Baskin, David Zhang, Jonathan New, Pamela Hicks, John Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. |
| title | Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. |
| title_full | Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. |
| title_fullStr | Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. |
| title_full_unstemmed | Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. |
| title_short | Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. |
| title_sort | autologous her2 cmv bispecific car t cells are safe and demonstrate clinical benefit for glioblastoma in a phase i trial. |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645467/ http://dx.doi.org/10.1186/2051-1426-3-S2-O11 |
| work_keys_str_mv | AT ahmednabil autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT brawleyvita autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT hegdemeenakshi autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT bielamowiczkevin autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT wakefieldamanda autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT ghazialexia autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT ashooriaidin autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT dioufoumar autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT gerkenclaudia autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT landidaniel autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT kalramamta autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT yizhongzhen autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT rooneycliona autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT dottigianpietro autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT geeadrian autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT heslophelen autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT gottschalkstephen autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT powellsuzanne autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT grossmanrobert autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT welswinfried autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT kewyzonne autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT baskindavid autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT zhangjonathan autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT newpamela autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial AT hicksjohn autologousher2cmvbispecificcartcellsaresafeanddemonstrateclinicalbenefitforglioblastomainaphaseitrial |